Julio A. Peguero

Also affiliated with Hematology Oncology Consultants

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Safety and clinical activity of target-preserving anti-CTLA-4 antibody ONC-392 as monotherapy in NSCLC patients who progressed on PD(L)1-targeted immunotherapy.”.

Safety and clinical activity of target-preserving anti-CTLA-4 antibody ONC-392 as monotherapy in NSCLC patients who progressed on PD(L)1-targeted immunotherapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9024

N/A

0.312DataRank · unranked

7 citations

David P. Carbone, Meredith McKean, Rama Balaraman, Satish Shah, Edward Arrowsmith +11 more

Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRAS G12C-Mutated Metastatic Colorectal Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0217

N/A

0DataRank · unranked

123 citations

Nataliya V. Uboha, Meredith S. Pelster, Tanios Bekaii‐Saab, Minal Barve, Joel Saltzman +12 more